These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 3158917)
21. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients. Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507 [TBL] [Abstract][Full Text] [Related]
22. [Clinical studies on the recurrence of urolithiasis (5). Diurnal variation in urinary pH and stone compositions]. Murayama T; Taguchi H Hinyokika Kiyo; 1988 Oct; 34(10):1711-5. PubMed ID: 3245520 [TBL] [Abstract][Full Text] [Related]
23. [The clinical applications in opthalmology of an original factor in cellular nutrition (piridoxylate]. Verin P; Sekkat A; Lagoutte F Arch Ophtalmol Rev Gen Ophtalmol; 1974 Jan; 34(1):65-74. PubMed ID: 4278378 [No Abstract] [Full Text] [Related]
24. Urinary magnesium and oxalic acid excretion in patients with recurrent oxalate urolithiasis. Takasaki E Invest Urol; 1975 Jan; 12(4):251-4. PubMed ID: 1112654 [TBL] [Abstract][Full Text] [Related]
25. [Drug-induced oxalic lithiasis from pyridoxilate]. Wolf C; Maistre-Charransol G; Barthelemy C; Thomas E; Thomas J Presse Med; 1984 Dec; 13(44):2703. PubMed ID: 6240037 [No Abstract] [Full Text] [Related]
31. Vitamin C and oxalate stones. Roth DA; Breitenfield RV JAMA; 1977 Feb; 237(8):768. PubMed ID: 576314 [No Abstract] [Full Text] [Related]
32. [Urinary oxalate in recurrent calcium urolithiasis with and without hyperfunctioning parathyroid glands and in healthy controls. influence of age and season (author's transl)]. Schwille PO; Paulus M; Scholz D; Sigel A; Wilhelm E Urologe A; 1979 Jul; 18(4):215-24. PubMed ID: 473457 [No Abstract] [Full Text] [Related]
34. [Indicators of the risk of calcium oxalate urinary calculi: comparative study of the Parks' and Tiselius' indices, urinary citrate/calciuria ratio, and morning crystalluria]. Robert M; Boularan AM; Guiter J; Monnier L Prog Urol; 1996 Apr; 6(2):264-8. PubMed ID: 8777421 [TBL] [Abstract][Full Text] [Related]
35. [Prolonged hemodynamic effects of pentaerythrityl tetranitrate combined with piridoxylate]. Baudet M; Hericotte P Sem Hop; 1983 Mar; 59(10):683-5. PubMed ID: 6304889 [TBL] [Abstract][Full Text] [Related]
36. [Oxalate: its role in lithogenesis and composition of calcium oxalate lithiasis]. Fernandez Rodríguez A; Arrabal Martín M; Domínguez Molinero JF; Mijan Ortiz JL; Sánchez Tamayo J; Zuluaga Gómez A Actas Urol Esp; 1995 Sep; 19(8):620-6. PubMed ID: 8669329 [TBL] [Abstract][Full Text] [Related]
37. [Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence]. Murayama T; Taguchi H Hinyokika Kiyo; 1988 Sep; 34(9):1543-7. PubMed ID: 3213790 [TBL] [Abstract][Full Text] [Related]
38. [Teecura - tea for the prevention of urinary calculi recurrence]. Bach D; Hesse A; Strenge A; Vahlensieck W ZFA (Stuttgart); 1981 May; 57(14):1113-8. PubMed ID: 7269761 [No Abstract] [Full Text] [Related]
39. [Studies on the etiology of urolithiasis: effects of vitamin B6 and vitamin B1 on urinary oxalate excretion]. Yachiku S; Okawa T; Takeuchi M; Sonoda T Hinyokika Kiyo; 1969 May; 15(5):297-303. PubMed ID: 5816782 [No Abstract] [Full Text] [Related]
40. [Studies of dietary influence on urinary oxalate in calcium oxalate stone formers]. Arima K Hinyokika Kiyo; 1983 Dec; 29(12):1587-603. PubMed ID: 6687143 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]